MedTrace Logo

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

NCT04204876 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-01-18

No results posted yet for this study

Summary

Longitudinal imaging in patients with large vessel vasculitis to predict further disease course

Conditions

  • Giant Cell Arteritis
  • Large Vessel Giant Cell Arteriitis

Interventions

DIAGNOSTIC_TEST

Magnet Resonance Imaging (MRI)

MRI with and without Gadolinium contrast agent for the following vessels: thoracic aorta (ascending, arch, descending arch, left and right common carotic, subclavian, and vertebral artery)

DIAGNOSTIC_TEST

PET/CT analysis

Standard value uptake measurement (SUV) based on quantitative score normalized to liver (SUV vessel max/liver mean) at the following vessel regions: Carotid artery: common, internal, external; Subclavian artery; Axillary artery; Vertebral artery; Thoracic Aorta; Abdominal Aorta; Common femoral artery; Deep femoral artery; Popliteal artery

Sponsors & Collaborators

  • Swiss Foundation for the Study of Muscular Diseases

    collaborator UNKNOWN

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Thomas Daikeler, Prof. Dr. MD · Department of Rheumatology, University Hospital Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2023-08-05
Completion
2023-08-05

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04204876 on ClinicalTrials.gov